Artisan Partners
AKRO

Artisan Partners’s Akero Therapeutics AKRO Stock Holding History

Artisan Partners’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-303,920
Closed -$7.68M – 336
2024
Q1 		$7.68M Hold
303,920
– – 0.01% 304
2023
Q4 		$7.1M Sell
303,920
-7,116
-2% -$140K 0.01% 306
2023
Q3 		$15.7M Buy
311,036
+73,452
+31% +$3.42M 0.03% 259
2023
Q2 		$11.1M Sell
237,584
-279
-0.1% -$12.8K 0.02% 268
2023
Q1 		$9.1M Sell
237,863
-602
-0.3% -$26.8K 0.02% 284
2022
Q4 		$13.1M Buy
+238,465
New +$10.2M 0.02% 271

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Artisan Partners's AKRO Position: Q2 2024 in Review

Artisan Partners sold out of Akero Therapeutics (AKRO) in Q2 2024, closing a stake of 303,920 shares — an estimated $7.68M sold.

Artisan Partners first reported a position in AKRO in Q4 2022 and held it in 6 quarters. The position peaked at $15.7M in Q3 2023. 153 funds tracked by Wall St. Rank hold AKRO as of Q2 2024.

  • Artisan Partners reported no remaining Akero Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Artisan Partners sold 303,920 Akero Therapeutics shares in Q2 2024, an estimated $7.68M.
  • Artisan Partners first reported a position in Akero Therapeutics in Q4 2022 and held it in 6 quarters.
  • Artisan Partners's Akero Therapeutics position peaked at $15.7M in Q3 2023.
  • 153 funds tracked by Wall St. Rank held Akero Therapeutics as of Q2 2024.

Based on Artisan Partners's 13F filing for Q2 2024, filed 12 Aug 2024.